Evidence map›Paper›PMID 37664599›Full record

ArticleiScience2023

DHHC2 regulates fear memory formation, LTP, and AKAP150 signaling in the hippocampus.

Meng-Die Li, Lu Wang, Yu-Qi Zheng, Dan-Hong Huang, Zhi-Xuan Xia, Jian-Min Liu, Dan Tian, Hui OuYang, Zi-Hao Wang, Zhen Huang and 8 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms and functions of protein S-acylation.Nature reviews. Molecular cell biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Meng-Die LiDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Lu WangDepartment of Nephrology, Fuzhou Children's Hospital of Fujian Province, Affiliated Hospital of Fujian Medical University, Fuzhou 350001, China.
Yu-Qi ZhengDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Dan-Hong HuangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Zhi-Xuan XiaDepartment of Pharmacology, School of Basic Medicine and Life Science, Hainan Medical University, Haikou 571199, China.
Jian-Min LiuDepartment of Pharmacy, Wuhan No. 1 Hospital, Wuhan 430000, China.
Dan TianDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Hui OuYangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Zi-Hao WangGuangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Zhen HuangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Xiao-Shan LinDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Xiao-Qian ZhuDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Si-Ying WangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Wei-Kai ChenDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Shao-Wei YangDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Yue-Ling ZhaoDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Jia-An LiuDepartment of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Zu-Cheng ShenDepartment of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
Fujian Medical University · CNWuhan No.1 Hospital · CNHainan Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palmitoyl acyltransferases (PATs) have been suggested to be involved in learning and memory. However, the underlying mechanisms have not yet been fully elucidated. Here, we found that the activity of DHHC2 was upregulated in the hippocampus after fear conditioning, and DHHC2 knockdown impaired fear induced memory and long-term potentiation (LTP). Additionally, the activity of DHHC2 and its synaptic expression were increased after high frequency stimulation (HFS) or glycine treatment. Importantly, fear learning selectively augmented the palmitoylation level of AKAP150, not PSD-95, and this effect was abolished by DHHC2 knockdown. Furthermore, 2-bromopalmitic acid (2-BP), a palmitoylation inhibitor, attenuated the increased palmitoylation level of AKAP150 and the interaction between AKAP150 and PSD-95 induced by HFS. Lastly, DHHC2 knockdown reduced the phosphorylation level of GluA1 at Ser845, and also induced an impairment of LTP in the hippocampus. Our results suggest that DHHC2 plays a critical role in regulating fear memory via AKAP150 signaling.

Indexed as

BiochemistryMolecular biologyNeuroscience

Identifiers

PMID37664599
PMCPMC10469764
OpenAlexW4385648822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.